Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

JXN vs MET

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
JXN
Jackson Financial Inc.

Insurance - Life

Financial ServicesNYSE • US
Market Cap$7.68B
5Y Perf.+323.5%
MET
MetLife, Inc.

Insurance - Life

Financial ServicesNYSE • US
Market Cap$51.39B
5Y Perf.+27.7%

JXN vs MET — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
JXN logoJXN
MET logoMET
IndustryInsurance - LifeInsurance - Life
Market Cap$7.68B$51.39B
Revenue (TTM)$5.86B$76.94B
Net Income (TTM)$-373M$3.62B
Gross Margin103.0%28.4%
Operating Margin-8.5%6.3%
Forward P/E4.7x8.0x
Total Debt$4.61B$20.18B
Cash & Equiv.$5.70B$22.03B

JXN vs METLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

JXN
MET
StockSep 21May 26Return
Jackson Financial I… (JXN)100423.5+323.5%
MetLife, Inc. (MET)100127.7+27.7%

Price return only. Dividends and distributions are not included.

Quick Verdict: JXN vs MET

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JXN leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. MetLife, Inc. is the stronger pick specifically for profitability and margin quality and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
JXN
Jackson Financial Inc.
The Insurance Pick

JXN carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 116.1%, EPS growth -102.0%, 3Y rev CAGR -11.7%
  • 288.5% 10Y total return vs MET's 153.9%
  • Lower volatility, beta 1.31, Low D/E 44.6%, current ratio 4.52x
Best for: growth exposure and long-term compounding
MET
MetLife, Inc.
The Insurance Pick

MET is the clearest fit if your priority is income & stability.

  • Dividend streak 13 yrs, beta 1.09, yield 2.9%
  • Combined ratio 0.9 vs JXN's 1.0 (lower = better underwriting)
  • Beta 1.09 vs JXN's 1.31
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthJXN logoJXN116.1% revenue growth vs MET's 10.2%
ValueJXN logoJXNLower P/E (4.7x vs 8.0x)
Quality / MarginsMET logoMETCombined ratio 0.9 vs JXN's 1.0 (lower = better underwriting)
Stability / SafetyMET logoMETBeta 1.09 vs JXN's 1.31
DividendsJXN logoJXN2.9% yield, 4-year raise streak, vs MET's 2.9%
Momentum (1Y)JXN logoJXN+36.5% vs MET's +4.9%
Efficiency (ROA)MET logoMET0.5% ROA vs JXN's -0.1%, ROIC 13.1% vs -0.9%

JXN vs MET — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

JXNJackson Financial Inc.
FY 2024
Retail Annuities Segment
75.9%$5.3B
Closed Life And Annuity Blocks Segment
17.8%$1.2B
Institutional Products Segment
6.3%$438M
METMetLife, Inc.
FY 2025
Prepaid legal plans and administrative-only contracts
26.1%$637M
Vision fee for service arrangements
23.0%$561M
Other revenue from service contracts from customers
17.7%$432M
Fee-based investment management services
15.1%$369M
Administrative Service
12.1%$295M
Distribution Service
5.8%$142M

JXN vs MET — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMETLAGGINGJXN

Income & Cash Flow (Last 12 Months)

MET leads this category, winning 4 of 6 comparable metrics.

MET is the larger business by revenue, generating $76.9B annually — 13.1x JXN's $5.9B. MET is the more profitable business, keeping 4.7% of every revenue dollar as net income compared to JXN's -6.4%. On growth, MET holds the edge at +4.4% YoY revenue growth, suggesting stronger near-term business momentum.

MetricJXN logoJXNJackson Financial…MET logoMETMetLife, Inc.
RevenueTrailing 12 months$5.9B$76.9B
EBITDAEarnings before interest/tax-$422M$5.9B
Net IncomeAfter-tax profit-$373M$3.6B
Free Cash FlowCash after capex$4.2B$16.5B
Gross MarginGross profit ÷ Revenue+103.0%+28.4%
Operating MarginEBIT ÷ Revenue-8.5%+6.3%
Net MarginNet income ÷ Revenue-6.4%+4.7%
FCF MarginFCF ÷ Revenue+71.0%+21.5%
Rev. Growth (YoY)Latest quarter vs prior year-22.1%+4.4%
EPS Growth (YoY)Latest quarter vs prior year-12.0%+35.9%
MET leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

JXN leads this category, winning 4 of 5 comparable metrics.
MetricJXN logoJXNJackson Financial…MET logoMETMetLife, Inc.
Market CapShares × price$7.7B$51.4B
Enterprise ValueMkt cap + debt − cash$6.6B$49.5B
Trailing P/EPrice ÷ TTM EPS-458.79x16.42x
Forward P/EPrice ÷ next-FY EPS est.4.67x8.05x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple8.66x
Price / SalesMarket cap ÷ Revenue1.15x0.67x
Price / BookPrice ÷ Book value/share0.75x1.81x
Price / FCFMarket cap ÷ FCF1.33x2.84x
JXN leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

MET leads this category, winning 7 of 9 comparable metrics.

MET delivers a 12.7% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $-4 for JXN. JXN carries lower financial leverage with a 0.45x debt-to-equity ratio, signaling a more conservative balance sheet compared to MET's 0.70x. On the Piotroski fundamental quality scale (0–9), MET scores 8/9 vs JXN's 7/9, reflecting strong financial health.

MetricJXN logoJXNJackson Financial…MET logoMETMetLife, Inc.
ROE (TTM)Return on equity-3.6%+12.7%
ROA (TTM)Return on assets-0.1%+0.5%
ROICReturn on invested capital-0.9%+13.1%
ROCEReturn on capital employed-0.0%+1.0%
Piotroski ScoreFundamental quality 0–978
Debt / EquityFinancial leverage0.45x0.70x
Net DebtTotal debt minus cash-$1.1B-$1.8B
Cash & Equiv.Liquid assets$5.7B$22.0B
Total DebtShort + long-term debt$4.6B$20.2B
Interest CoverageEBIT ÷ Interest expense-4.22x5.51x
MET leads this category, winning 7 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JXN leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in JXN five years ago would be worth $38,852 today (with dividends reinvested), compared to $13,291 for MET. Over the past 12 months, JXN leads with a +36.5% total return vs MET's +4.9%. The 3-year compound annual growth rate (CAGR) favors JXN at 49.8% vs MET's 16.7% — a key indicator of consistent wealth creation.

MetricJXN logoJXNJackson Financial…MET logoMETMetLife, Inc.
YTD ReturnYear-to-date+3.3%-1.2%
1-Year ReturnPast 12 months+36.5%+4.9%
3-Year ReturnCumulative with dividends+236.0%+58.9%
5-Year ReturnCumulative with dividends+288.5%+32.9%
10-Year ReturnCumulative with dividends+288.5%+153.9%
CAGR (3Y)Annualised 3-year return+49.8%+16.7%
JXN leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

MET leads this category, winning 2 of 2 comparable metrics.

MET is the less volatile stock with a 1.09 beta — it tends to amplify market swings less than JXN's 1.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MET currently trades 94.2% from its 52-week high vs JXN's 89.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricJXN logoJXNJackson Financial…MET logoMETMetLife, Inc.
Beta (5Y)Sensitivity to S&P 5001.31x1.09x
52-Week HighHighest price in past year$123.61$83.64
52-Week LowLowest price in past year$78.76$67.33
% of 52W HighCurrent price vs 52-week peak+89.1%+94.2%
RSI (14)Momentum oscillator 0–10058.067.1
Avg Volume (50D)Average daily shares traded540K3.5M
MET leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Evenly matched — JXN and MET each lead in 1 of 2 comparable metrics.

Wall Street rates JXN as "Hold" and MET as "Buy". Consensus price targets imply 22.4% upside for MET (target: $97) vs 9.0% for JXN (target: $120). For income investors, JXN offers the higher dividend yield at 2.88% vs MET's 2.88%.

MetricJXN logoJXNJackson Financial…MET logoMETMetLife, Inc.
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$120.00$96.50
# AnalystsCovering analysts633
Dividend YieldAnnual dividend ÷ price+2.9%+2.9%
Dividend StreakConsecutive years of raises413
Dividend / ShareAnnual DPS$3.17$2.27
Buyback YieldShare repurchases ÷ mkt cap+8.7%+7.6%
Evenly matched — JXN and MET each lead in 1 of 2 comparable metrics.
Key Takeaway

MET leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). JXN leads in 2 (Valuation Metrics, Total Returns). 1 tied.

Best OverallMetLife, Inc. (MET)Leads 3 of 6 categories
Loading custom metrics...

JXN vs MET: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is JXN or MET a better buy right now?

For growth investors, Jackson Financial Inc.

(JXN) is the stronger pick with 116. 1% revenue growth year-over-year, versus 10. 2% for MetLife, Inc. (MET). MetLife, Inc. (MET) offers the better valuation at 16. 4x trailing P/E (8. 0x forward), making it the more compelling value choice. Analysts rate MetLife, Inc. (MET) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — JXN or MET?

On forward P/E, Jackson Financial Inc.

is actually cheaper at 4. 7x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — JXN or MET?

Over the past 5 years, Jackson Financial Inc.

(JXN) delivered a total return of +288. 5%, compared to +32. 9% for MetLife, Inc. (MET). Over 10 years, the gap is even starker: JXN returned +288. 5% versus MET's +153. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — JXN or MET?

By beta (market sensitivity over 5 years), MetLife, Inc.

(MET) is the lower-risk stock at 1. 09β versus Jackson Financial Inc. 's 1. 31β — meaning JXN is approximately 21% more volatile than MET relative to the S&P 500. On balance sheet safety, Jackson Financial Inc. (JXN) carries a lower debt/equity ratio of 45% versus 70% for MetLife, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — JXN or MET?

By revenue growth (latest reported year), Jackson Financial Inc.

(JXN) is pulling ahead at 116. 1% versus 10. 2% for MetLife, Inc. (MET). On earnings-per-share growth, the picture is similar: MetLife, Inc. grew EPS -19. 2% year-over-year, compared to -102. 0% for Jackson Financial Inc.. Over a 3-year CAGR, MET leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — JXN or MET?

MetLife, Inc.

(MET) is the more profitable company, earning 4. 4% net margin versus 0. 4% for Jackson Financial Inc. — meaning it keeps 4. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MET leads at 6. 0% versus -1. 7% for JXN. At the gross margin level — before operating expenses — JXN leads at 85. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is JXN or MET more undervalued right now?

On forward earnings alone, Jackson Financial Inc.

(JXN) trades at 4. 7x forward P/E versus 8. 0x for MetLife, Inc. — 3. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MET: 22. 4% to $96. 50.

08

Which pays a better dividend — JXN or MET?

All stocks in this comparison pay dividends.

Jackson Financial Inc. (JXN) offers the highest yield at 2. 9%, versus 2. 9% for MetLife, Inc. (MET).

09

Is JXN or MET better for a retirement portfolio?

For long-horizon retirement investors, MetLife, Inc.

(MET) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 09), 2. 9% yield, +153. 9% 10Y return). Both have compounded well over 10 years (MET: +153. 9%, JXN: +288. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between JXN and MET?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: JXN is a small-cap high-growth stock; MET is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

JXN

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 61%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

MET

Income & Dividend Stock

  • Sector: Financial Services
  • Market Cap > $100B
  • Gross Margin > 17%
  • Dividend Yield > 1.1%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform JXN and MET on the metrics below

Revenue Growth>
%
(JXN: -22.1% · MET: 4.4%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.